Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ida Nikoline Mandic1, Victoria Elizabeth de Knegt2, Hristo Stanchev1

  • 1Børne- og Ungeafdeling, Københavns Universitetshospital - Slagelse Sygehus.

Ugeskrift for Laeger
|July 2, 2024
PubMed
Summary

Risk-based screening and antibiotics reduced early-onset Group B Streptococcus (GBS) disease in neonates but not late-onset disease. Antibiotic stewardship and a future GBS vaccine may further reduce infant GBS disease and antibiotic exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological-Based Cord Clamping and Early Oxygenation in Newborns With Transposition of the Great Arteries: A Quality Improvement Study Protocol.

CJC pediatric and congenital heart disease·2026
Same author

Assessment of dried blood spot and umbilical cord blood samples for the quantification of maternally transferred IgG against the group B streptococcal alpha-like surface proteins in neonates at Kolding Hospital, Denmark: a proof-of-concept, cross-sectional study.

The Lancet. Microbe·2026
Same author

Individualised duration of antibiotic treatment in culture-negative early-onset sepsis in late-preterm and term-born neonates in Denmark (DURATION): a multicentre, open-label, randomised, controlled, non-inferiority trial.

The Lancet. Child & adolescent health·2026
Same author

Surfactant administration via supraglottic airway in premature infants (SALSA): a survey-based assessment of current procedural practice.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Sepsis and Antibiotics in Extremely Preterm Infants: Early Empirical Treatment Was Common, While Late-Onset Sepsis Accounted for Most Cases and Antibiotic Use.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Early-Onset Neonatal Infection and Cerebral Palsy.

JAMA network open·2026

Area of Science:

  • Neonatal infectious diseases
  • Bacterial pathogenesis
  • Public health interventions

Background:

  • Group B Streptococcus (GBS) causes neonatal disease in early-onset (EOD) and late-onset (LOD) forms.
  • Intrapartum screening and antibiotic administration are standard prevention strategies.
  • Current diagnostic methods cannot exclude GBS disease at symptom onset.

Purpose of the Study:

  • To evaluate the impact of risk-based intrapartum screening and antibiotic use on EOD and LOD incidence in Denmark.
  • To assess the extent of antibiotic exposure in neonates and identify potential reductions.
  • To explore future strategies for GBS disease prevention, including vaccination.

Main Methods:

  • Review of data on GBS disease incidence in Denmark.

Related Experiment Videos

  • Analysis of trends in EOD and LOD following implementation of screening protocols.
  • Assessment of antibiotic usage patterns in neonates with suspected GBS disease.
  • Main Results:

    • Risk-based intrapartum screening and antibiotics significantly reduced EOD incidence.
    • No significant reduction in LOD incidence was observed.
    • A substantial proportion of uninfected infants received antibiotics, with wide variations in practice.
    • Antibiotic stewardship strategies show potential for reducing unnecessary antibiotic exposure.

    Conclusions:

    • Intrapartum GBS screening effectively reduces EOD but not LOD.
    • Strategies for antibiotic stewardship are crucial to minimize unnecessary antibiotic use in neonates.
    • A GBS vaccine for pregnant women represents a promising future approach to decrease GBS disease burden and antibiotic exposure.